Charles Zhu
Stock Analyst at Guggenheim
(2.81)
# 2,049
Out of 5,058 analysts
27
Total ratings
56.52%
Success rate
22.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Zhu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics | Maintains: Buy | $10 → $12 | $8.29 | +44.84% | 4 | Oct 24, 2025 | |
| MRUS Merus | Downgrades: Market Perform | $97 | $96.04 | +1.00% | 7 | Sep 30, 2025 | |
| CBIO Crescent Biopharma | Initiates: Outperform | $22 | $13.03 | +68.84% | 1 | Jun 18, 2025 | |
| RPTX Repare Therapeutics | Downgrades: Market Perform | n/a | $2.15 | - | 1 | Dec 13, 2024 | |
| MGNX MacroGenics | Upgrades: Buy | $12 | $1.42 | +745.07% | 4 | Nov 7, 2023 | |
| NUVL Nuvalent | Initiates: Buy | $56 | $107.13 | -47.73% | 1 | Jul 24, 2023 | |
| TARA Protara Therapeutics | Assumes: Buy | $22 | $6.71 | +227.87% | 1 | Jul 10, 2023 | |
| COGT Cogent Biosciences | Reiterates: Buy | $26 | $34.94 | -25.59% | 3 | Jun 13, 2023 | |
| IDYA IDEAYA Biosciences | Reiterates: Buy | $32 | $33.13 | -3.41% | 3 | Mar 8, 2023 | |
| ZYME Zymeworks | Upgrades: Buy | $14 | $22.60 | -38.05% | 2 | May 5, 2022 |
Tango Therapeutics
Oct 24, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $8.29
Upside: +44.84%
Merus
Sep 30, 2025
Downgrades: Market Perform
Price Target: $97
Current: $96.04
Upside: +1.00%
Crescent Biopharma
Jun 18, 2025
Initiates: Outperform
Price Target: $22
Current: $13.03
Upside: +68.84%
Repare Therapeutics
Dec 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $2.15
Upside: -
MacroGenics
Nov 7, 2023
Upgrades: Buy
Price Target: $12
Current: $1.42
Upside: +745.07%
Nuvalent
Jul 24, 2023
Initiates: Buy
Price Target: $56
Current: $107.13
Upside: -47.73%
Protara Therapeutics
Jul 10, 2023
Assumes: Buy
Price Target: $22
Current: $6.71
Upside: +227.87%
Cogent Biosciences
Jun 13, 2023
Reiterates: Buy
Price Target: $26
Current: $34.94
Upside: -25.59%
IDEAYA Biosciences
Mar 8, 2023
Reiterates: Buy
Price Target: $32
Current: $33.13
Upside: -3.41%
Zymeworks
May 5, 2022
Upgrades: Buy
Price Target: $14
Current: $22.60
Upside: -38.05%